Pneumococcal pneumonia and influenza: A deadly combination

被引:105
|
作者
Klugman, Keith P. [1 ,2 ]
Chien, Yu-Wen [1 ]
Madhi, Shabir A. [2 ,3 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa
[3] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa
关键词
Pneumococcal pneumonia; Influenza; PCV7; COMMUNITY-ACQUIRED PNEUMONIA; CONJUGATE VACCINE EFFICACY; C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; PANDEMIC INFLUENZA; STANDARDIZED INTERPRETATION; HOSPITALIZED CHILDREN; RESPIRATORY-INFECTION; BACTERIAL PNEUMONIA; CHEST RADIOGRAPHS;
D O I
10.1016/j.vaccine.2009.06.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Significant morbidity due to pneumococcal co-infection is associated with viral respiratory infections. Pneumonia is the leading cause of death in children worldwide. The incidence of clinical pneumonia among children in the United States decreased 39% following the introduction of a seven-valent pneumococcal conjugate vaccine (PCV). PCVs have also reduced hospitalisations associated with influenza in children. The majority of the mortality associated with the influenza pandemic of 1918 was attributable to bacterial infections, especially the pneumococcus. Vaccination with PCV for children and pneumococcal polysaccharide vaccine for adults should be considered essential to pandemic influenza preparedness. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:C9 / C14
页数:6
相关论文
共 50 条
  • [31] Novel influenza A antibodies reduce severity of secondary pneumococcal pneumonia after influenza infection in mice
    KF Van der Sluijs
    F Van Someren Greve
    MD De Jong
    MJ Schultz
    NP Juffermans
    Critical Care, 19 (Suppl 1):
  • [32] Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
    Metersky, Mark L.
    Masterton, Robert G.
    Lode, Hartmut
    File, Thomas M., Jr.
    Babinchak, Timothy
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (05) : E321 - E331
  • [33] Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive Streptococcus pneumoniae to Cause Deadly Pneumonia
    Verma, Atul K.
    Bansal, Shruti
    Bauer, Christopher
    Muralidharan, Abenaya
    Sun, Keer
    JOURNAL OF IMMUNOLOGY, 2020, 205 (06) : 1601 - 1607
  • [34] Assessment of a urinary antigen test in inpatients with pneumococcal pneumonia
    Naeini, Alireza Emami
    Ataei, Behrooz
    Shirani, Kiana
    Akbari, Mojtaba
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 : S183 - S186
  • [35] Emerging drugs for pneumococcal pneumonia
    Falco, Vicenc
    Sanchez, Ana
    Pahissa, Albert
    Rello, Jordi
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (03) : 459 - 477
  • [36] Diabetes Mellitus and Pneumococcal Pneumonia
    Cilloniz, Catia
    Torres, Antoni
    DIAGNOSTICS, 2024, 14 (08)
  • [37] Pneumococcal pneumonia: differences according to blood culture results
    Capelastegui, Alberto
    Zalacain, Rafael
    Bilbao, Amaia
    Egurrola, Mikel
    Ruiz Iturriaga, Luis Alberto
    Quintana, Jose M.
    Gomez, Ainhoa
    Esteban, Cristobal
    Espana, Pedro P.
    BMC PULMONARY MEDICINE, 2014, 14
  • [38] How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia
    von Baum, H.
    Schweiger, B.
    Welte, T.
    Marre, R.
    Suttorp, N.
    Pletz, M. W. R.
    Ewig, S.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (05) : 1151 - 1157
  • [39] Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection
    Metzger, Dennis W.
    Furuya, Yoichi
    Salmon, Sharon L.
    Roberts, Sean
    Sun, Keer
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (03) : 445 - 452
  • [40] Influenza and pneumococcal vaccination: an update
    Roberts, H. J.
    Lim, W. S.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2007, 37 (03) : 228 - 231